Phase II Trial of Methylene Blue in Alzheimer's Disease

Phase II Trial of Methylene Blue in Alzheimer's Disease https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209349/ This 24-week phase II clinical trial involved 321 patients with mild-to-moderate Alzhei...